rs137852777

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PP3_StrongBS2

The NM_018100.4(EFHC1):​c.628G>A​(p.Asp210Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D210V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

EFHC1
NM_018100.4 missense

Scores

8
6
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1O:1

Conservation

PhyloP100: 7.76

Publications

4 publications found
Variant links:
Genes affected
EFHC1 (HGNC:16406): (EF-hand domain containing 1) This gene encodes an EF-hand-containing calcium binding protein. The encoded protein likely plays a role in calcium homeostasis. Mutations in this gene have been associated with susceptibility to juvenile myoclonic epilepsy and juvenile absence epilepsy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
EFHC1 Gene-Disease associations (from GenCC):
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.943
BS2
High AC in GnomAdExome4 at 17 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFHC1NM_018100.4 linkc.628G>A p.Asp210Asn missense_variant Exon 4 of 11 ENST00000371068.11 NP_060570.2 Q5JVL4-1B2CKC5
EFHC1NM_001172420.2 linkc.571G>A p.Asp191Asn missense_variant Exon 5 of 12 NP_001165891.1 Q5JVL4-3B2CKC5
EFHC1NR_033327.2 linkn.697G>A non_coding_transcript_exon_variant Exon 4 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFHC1ENST00000371068.11 linkc.628G>A p.Asp210Asn missense_variant Exon 4 of 11 1 NM_018100.4 ENSP00000360107.4 Q5JVL4-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000477
AC:
12
AN:
251428
AF XY:
0.0000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000116
AC:
17
AN:
1461874
Hom.:
0
Cov.:
32
AF XY:
0.0000124
AC XY:
9
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1112006
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000134
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000576
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Uncertain:1
Feb 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 210 of the EFHC1 protein (p.Asp210Asn). This variant is present in population databases (rs137852777, gnomAD 0.04%). This missense change has been observed in individual(s) with clinical features of juvenile myoclonic epilepsy (PMID: 15258581, 18823326, 22727576, 34645491). ClinVar contains an entry for this variant (Variation ID: 2065). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EFHC1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects EFHC1 function (PMID: 15258581, 22226147, 22926142). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Myoclonic epilepsy, juvenile, susceptibility to, 1 Other:1
Aug 01, 2004
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.72
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.23
T;.;.;D;T;T;T;T;T;.;T;.;T;.
Eigen
Pathogenic
0.99
Eigen_PC
Pathogenic
0.95
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D;D;.;D;D;D;D;D;D;D;D;.;.;D
M_CAP
Benign
0.066
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.44
D
MutationAssessor
Pathogenic
3.7
.;.;.;H;.;.;.;.;.;.;.;.;.;.
PhyloP100
7.8
PrimateAI
Uncertain
0.50
T
PROVEAN
Pathogenic
-4.8
.;.;.;D;.;.;.;.;.;.;.;.;.;D
REVEL
Uncertain
0.62
Sift
Uncertain
0.0060
.;.;.;D;.;.;.;.;.;.;.;.;.;D
Sift4G
Uncertain
0.010
.;.;.;D;.;.;.;.;.;.;.;.;.;D
Polyphen
1.0
.;.;.;D;.;.;.;.;.;.;.;.;.;.
Vest4
0.95, 0.96
MutPred
0.91
.;.;.;Gain of catalytic residue at D210 (P = 0.05);Gain of catalytic residue at D210 (P = 0.05);Gain of catalytic residue at D210 (P = 0.05);Gain of catalytic residue at D210 (P = 0.05);Gain of catalytic residue at D210 (P = 0.05);.;Gain of catalytic residue at D210 (P = 0.05);.;.;.;.;
MVP
0.99
MPC
0.44
ClinPred
0.99
D
GERP RS
6.1
Varity_R
0.65
gMVP
0.79
Mutation Taster
=9/91
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852777; hg19: chr6-52317540; API